Sentences with phrase «drug discovery industry»

To coincide with the annual meeting of British Pharmacological Society, senior representatives from two of the country's leading academic societies outlined the case for drug discovery industry in the UK.
The Canadian drug discovery industry is still small, especially in comparison to the United States, owing to the lack of big pharmaceutical companies conducting research and development in this country.

Not exact matches

«It just felt like there was this massive amount of waste,» she says, referring to the billions of dollars the pharma industry annually plunges into drug discovery, with diminishing results.
These companies were early developers of drug discovery tools, and were part of an industry wide acquisition roll - up that resulted in Accelrys.
As an investment, a drug that is in the discovery or pre-clinical stage is a very risky proposition, with less than a 1 % chance of getting to market (according to an industry report published in 2003 by the Pharmaceutical Research and Manufacturers of America).
«These are companies using artificial intelligence in industries from drug discovery and cybersecurity to robotics and legal tech.
But there is no industry I can think of — no sport, no science, no game, no writing, no legal system, no athletic ability, no engineering, no drug discovery, no awards for scientific achievement, no Fortune 50 companies (companies that actually make something in addition to money), no adventurism, no culinary art, no nothing in which a woman sits above all men in her field.
One because he made a MAJOR, impactful, amazing discovery that changes the game of genetics, the other because he * already worked in industry * before he got his PhD and got 3 patents during grad school, one for a marketable drug.
Zhi Hong, Ribapharm's vice president of drug discovery, said, «From the pharmaceutical industry point of view, I see immunotherapy as the most exciting aspect of immunology.»
Recently, though, the drug discovery components of the business have begun to provide some of the industry's more intellectually challenging and financially rewarding jobs.
But industry also looks forward to change, particularly in drug discovery.
Although the pharmaceutical industry, like the rest of the business world, has suffered a slowdown, the market research company Frost and Sullivan still expects spending on drug discovery to expand from US$ 19.6 billion in 2002 to US$ 25.6 billion by 2006, an annual growth rate of about 6 %.
A Career in Drug Discovery and Development Wolfgang Sadée, professor of pharmacology at Ohio State University, offers an overview of drug discovery in the pharmaceutical industry and outlines the range of opportunities available to students who are interested in moving into this dynamic fiDrug Discovery and Development Wolfgang Sadée, professor of pharmacology at Ohio State University, offers an overview of drug discovery in the pharmaceutical industry and outlines the range of opportunities available to students who are interested in moving into this dynamic fidrug discovery in the pharmaceutical industry and outlines the range of opportunities available to students who are interested in moving into this dynamic field.
While helping make the entire industry more productive, these new programs add yet another element to the continuing education of drug discovery researchers.
To give you a sense of where the arena is headed, we'll also describe over the course of the month new industry initiatives that are intended to improve the drug discovery process.
Those moves represent a shift by Pfizer toward a more specialized approach to drug discovery and follow another trend in the industry: streamlining R&D by focusing on specific disease areas — a strategy biotechs already employ albeit on a smaller scale.
In the first week of the feature and continuing throughout the month, Next Wave will explore drug discovery opportunities in industry by highlighting the experiences of researchers working for larger and more established companies, as well as the motivations of an individual who chose a drug discovery start - up.
At the same time, my learning curve was steep as I interacted with the talented chemists, expanded my repertoire of techniques (in particular with mass spectroscopy), and generally learned about the drug - discovery side of the industry.
«Usually people say that drug discovery and development can not happen strictly in the academic environment, that discovery should be done in academia, and development done elsewhere, such as in industry,» said Radu.
Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective, has become an international «industry standard,» linking the frontiers of life science innovation and drug discovery with the policies and programs driving them forward.
Today, job prospects within computational biology — also known as bioinformatics — seem strong and appear to be growing, buoyed by pharmaceutical and biotech industries looking to take advantage of reams of genomics data and usher in a new era of drug discovery.
Lowe, a medical chemist by profession, provides daily commentary on drug discoveries, the pharmaceutical industry, and relevant research and news, especially in chemistry.
Although SB 247464 doesn't work with human cells, the discovery will spur the pharmaceutical industry's search for protein - mimicking drugs, says Mark Goldsmith, who studies cytokine receptors at the University of California, San Francisco.
► This week, In the Pipeline, Derek Lowe's popular drug discovery and the pharma industry blog, moved to the Science Translational Medicine site.
Tracy began as an industry researcher and within a year had moved to the drug - discovery department at her pharma employer.
Often, though, the financial challenge of drug discovery leads academic scientists to collaborate with industry.
Researchers there are convinced that these technologies will increase the chance for serendipitous discoveries, accelerate the speed of delivering new drugs to market and advance the industry as a whole toward personalized medicine.
«We are very strong in drug discovery, but we don't have a strong local pharmaceutical industry,» she says.
Nevertheless, Canadian job opportunities in drug discovery are on the rise, Harack declares, as the local biotechnology industry enters its «early teen» phase, growing from early stage R&D to development and commercialization.
Working on the premise that scientific research is the foundation of any technology industry, Hancock and others at UBC are writing a business proposal for an integrative centre for drug research, with an objective of developing intellectual property in drug discovery, providing training for drug discovery researchers, and developing new technologies.
I worked in metabolic disease drug discovery in the pharmaceutical industry for more than 22 years.
«While we celebrate the «a ha» moment of scientific discovery and invention, such moments are only the point of initiation for the basic research required to develop new drugs,» said Dr. Laura McNamee, the lead author of the paper and a research associate in Bentley's Center for Integration of Science and Industry.
The pharmaceutical industry is research and development driven, given that company growth and viability are dependent on the discovery of new drug molecules.
The drying drug pipeline and looming patent cliff, together with the ailing economy, has hit the drug discovery business hard, forcing the industry to lay off workers and rethink and restructure its research and development models.
As industry giants lose patent rights on big - money drugs such as Lipitor and Plavix, they are looking to offset lost revenues by cutting costs and lowering exposure to the risks and expenses of drug discovery and development.
I had this discovery that could undermine a $ 3 billion industry, not just the drugs but the entire field of endoscopy.
This has resulted in industry laboratories dedicated to drug discovery or human genome research.
«Industry jobs do tend to prize creativity, but within the confines of a predefined goal,» says Paul M. Matthews, vice president for imaging and head of the GlaxoSmithKline Clinical Imaging Centre in Hammersmith Hospital within the company's drug discovery division.
«Techniques like this one that enable controlled, remote C - H activation are just beginning to be adopted by industry, and should provide a boost to drug discovery and development efforts for many years to come,» Yu said.
The convergence of several factors explains the trend: cheaper genetic sequencing technologies, the discovery of new oncogenes (genes that can cause a normal cell to become cancerous), a new generation of computers and bioinformatics that can analyze vast amounts of data, and a multibillion - dollar effort by researchers inside and outside the pharma industry to develop targeted drugs and companion diagnostics for cancer.
Given how much money there is in the industry, it is not surprising that biotech is most prominent in drug discovery and pharmaceuticals.
Essentially, the model for the drug discovery process in academia is the same as in industry.
Drug discovery in academia, because of the financial constraints, is on a much smaller scale than industry and therefore allows «hands - on» experience of several stages in the process as well as more extensive training in a single area.
The role played by organic chemistry in the pharmaceutical industry continues to be one of the main drivers in the drug discovery process.
Highlights SciLifeLab DDD platform reaches out to Swedish academia with an industry - standard infrastructure for academic drug discovery.
The SGC is a global network of experienced academic and industry scientists that will contribute expertise in the development of reagents required for target validation and drug discovery.
12 years of expertise in metabolomics for drug discovery in the pharmaceutical industry and in the development of innovative analytical methods for biomarker analysis, with experience in metabolomics and imaging technologies coupling.
The initiative will also allow the CMI to foster new partnerships between academia and industry, and utilize the individual strengths that each possess to expedite the early stages of small molecule drug discovery.
To help Gladstone discoveries successfully cross through the valley of death, the Hellman Family Foundation Alzheimer's Research Program subsidizes the myriad of early - stage, de-risking tests necessary to make a drug candidate more attractive to pharmaceutical - industry partners, such as tests that reveal at what concentrations a drug stops being therapeutic and instead becomes toxic.
This effort will combine academic groundbreaking discoveries with drug discovery expertise and development traditionally only found in the pharmaceutical industry.
a b c d e f g h i j k l m n o p q r s t u v w x y z